# Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
Canonical URL: https://biopharmsignal.com/news/PRME/prime-medicine-reports-third-quarter-2025-financial-results-and-provides-business-updates
Ticker: PRME
Company: Prime Medicine
Source: Prime Medicine
Published: 2025-11-07 12:00 EST
Original Source URL: https://investors.primemedicine.com
## Summary

-- New preclinical data for PM577 in Wilson’s Disease (WD) to be presented at AASLD; on-track to file IND and/or CTA in H1’26, with initial clinical data expected in 2027 --  -- Nominated PM647 as development candidate for Alpha-1 Antitrypsin Deficiency (AATD); on-track to file IND and/or CTA in

## Article Body
-- New preclinical data for PM577 in Wilson’s Disease (WD) to be presented at AASLD; on-track to file IND and/or CTA in H1’26, with initial clinical data expected in 2027 --  -- Nominated PM647 as development candidate for Alpha-1 Antitrypsin Deficiency (AATD); on-track to file IND and/or CTA in
## Recent Company News
- 2026-06-03 12:00 EST — [Prime Medicine to Present at Goldman Sachs 47th Annual Global Healthcare Conference](https://biopharmsignal.com/news/PRME/prime-medicine-to-present-at-goldman-sachs-47th-annual-global-healthcare-conference) — Source: Prime Medicine
- 2026-05-07 12:00 EST — [Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates](https://biopharmsignal.com/news/PRME/prime-medicine-reports-first-quarter-2026-financial-results-and-provides-business-updates) — Source: Prime Medicine
- 2026-04-16 12:00 EST — [Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer](https://biopharmsignal.com/news/PRME/prime-medicine-appoints-svetlana-makhni-as-chief-financial-officer) — Source: Prime Medicine
- 2026-03-03 13:00 EST — [Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates](https://biopharmsignal.com/news/PRME/prime-medicine-reports-full-year-2025-financial-results-and-provides-business-updates) — Source: Prime Medicine
- 2026-02-25 13:00 EST — [Prime Medicine to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/PRME/prime-medicine-to-participate-in-upcoming-investor-conferences) — Source: Prime Medicine
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)